| Followers | 35 |
| Posts | 2798 |
| Boards Moderated | 0 |
| Alias Born | 10/28/2013 |
Thursday, May 22, 2014 4:57:14 PM
I do know someone with lung tumor that were "killed" by radiation and chemo whose been told the necrotic tumors may never go away. Not sure he used the term necrotic, but that is the picture in my memory. Black and thin.
I wonder whether those severely hindered (or dead) tumors would go away if he was not receiving regular chemo. Between the radiation and continued chemo, his immune system might be greatly impaired.
In this case, the radiation and chemo worked. He has been functional for years this way. Though he does have major scarring from the radiation. And the monthly (I think it was monthly) chemo makes him pretty weak for a few days after.
I am hopeful that DCVax-Direct finishes the job. If the tumor cells are really dead, then maybe it doesn't matter a great deal how long it takes for the body to metabolize them. But of course, if just one cell is left living, it could be Friday the 13th with Jason getting back up after being shot 6 times. I agree. I understand.
I am interested to find out if they induce a fever with DCVax-Direct. They may not. So my hopes that a full red-alert for the broad immune system may be unfounded. But maybe they do induce a full response. If not, it would be a logical addition to the therapy in my current guesswork. As would rotating the Coley's Toxin component between injections, or upping the toxin dose with each injection as they found was optimum way back when.
That chemo, by the way, which he expect to continue for the rest of his life, costs over $100K per year.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
